Schistosoma Mansoni: Clinical Trials

11 trials for Schistosoma Mansoni, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 not yet recruiting, 1 withdrawn. 4 Not applicable, 4 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Unknown 1
Phase 24Completed 2, Not yet recruiting 1, Unknown 1
Phase 34Completed 3, Not yet recruiting 1
Phase 11Completed 1

Follow Schistosoma Mansoni: new trials by email Literature Review of Schistosoma Mansoni trials Research Report on Schistosoma Mansoni

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis
Praziquantel 40 mg/kg per dose given once annually, Praziquantel 40 mg/kg given three times per year - Schistosomiasis, Schistosoma Mansoni
Phase 2 / Phase 3Not yet recruitingRhode Island Hospital6002026-11-012026-08-12
Sm-p80 Schistosomiasis Challenge Study
Sm-p80 + GLA-SE Vaccine, Placebo, Schistosoma mansoni infection - Schistosoma Mansoni, Schistosomiasis
Phase 2UnknownLeiden University Medical Center482024-09-012023-10-17
Repeated Controlled Human Schistosoma Mansoni Infection
Schistosoma mansoni infection, Placebo mock infection - Schistosomiasis, Schistosoma Mansoni
Not applicableCompletedLeiden University Medical Center242021-10-292023-01-30
Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni
Ujiplus®, Praziquantel 400mg - Schistosoma Mansoni
Phase 2 / Phase 3CompletedKenya Medical Research Institute4002021-05-062022-07-12
Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach
Molecular biology analyses - Schistosoma Mansoni
Not applicableUnknownIRCCS Sacro Cuore Don Calabria di Negrar2002021-04-142024-03-15
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
Praziquantel, Artesunate + Mefloquine - Schistosoma Haematobium, Schistosoma Mansoni
Phase 3CompletedInstitute of Tropical Medicine, Belgium7262019-10-142021-04-05
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701, ENGERIX-B Hepatitis B Vaccine - Schistosomiasis, Schistosoma Mansoni
Phase 1 / Phase 2CompletedBaylor College of Medicine2902019-10-072025-11-04
Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding
male Schistosoma mansoni cercariae - Schistosomiasis, Schistosoma Mansoni
Not applicableCompletedLeiden University172016-10-272020-11-18
Leiden University Medical Center Mini Donor Bank
Malaria, Schistosoma Mansoni
WithdrawnLeiden University Medical Center2016-05-312017-08-29
Schistosoma Mansoni in Mwanza Region, Tanzania
Praziquantel - Schistosoma Mansoni
Not applicableCompletedDBL -Institute for Health Research and Development375002011-03-012017-02-10
A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni
Artesunate+Sulfamethoxypyrazine/pyrimethamine, Praziquantel - Schistosoma Mansoni
Phase 3CompletedKenya Medical Research Institute2122009-10-012010-01-22

Narrower conditions

Schistosomiasis (11)  ·  Schistosomiasis haematobia (2)  ·  Asthma (1)  ·  Diabetes Mellitus (1)  ·  Hypertension, Portal (1)  ·  Liver Cirrhosis (1)  ·  Malaria (1)

Broader conditions

Helminthiasis (11)  ·  Infections (11)  ·  Parasitic Diseases (11)  ·  Trematode Infections (11)  ·  Vector Borne Diseases (11)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Urinary Tract Infections (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Bronchial Diseases (1)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Fibrosis (1)

Interventions

Praziquantel (5)  ·  Artesunate (1)  ·  Mefloquine (1)  ·  Pyrimethamine (1)

Sponsors

Leiden University Medical Center (3)  ·  Kenya Medical Research Institute (2)  ·  Baylor College of Medicine (1)  ·  DBL -Institute for Health Research and Development (1)  ·  IRCCS Sacro Cuore Don Calabria di Negrar (1)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Leiden University (1)  ·  Rhode Island Hospital (1)

Countries

Kenya (2)  ·  Netherlands (2)  ·  Uganda (2)  ·  Italy (1)  ·  Senegal (1)  ·  Tanzania (1)

Top investigators

Elijah M Songok, PhD (1)  ·  Hannah Kibuuka, MD (1)  ·  Meta Roestenberg (1)  ·  Meta Roestenberg, Prof (1)  ·  Moustapha Mbow, MD (1)  ·  Pauline N Mwinzi, PhD (1)  ·  Safari Kinung'hi, PhD (1)

Results publications

PMID 20705516, PMID 30615787, PMID 32066978, PMID 34168029, PMID 38177851, PMID 39666392

NIH funding

R01AI184979 (1)